John Richard Pinion
EVP, Chief Quality Operations Officer · Ultragenyx Pharmaceutical Inc.
- 2026
- Apr 20, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies John Richard Pinion files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Emil D. Kakkis - $1.24M in RARE purchases and sales in the last 12 months
- Howard Horn - $1.08M in RARE purchases and sales in the last 12 months
- Karah Herdman Parschauer - $488K in RARE purchases and sales in the last 12 months
- Erik Harris - $240K in RARE purchases and sales in the last 12 months
- Eric Crombez - $169K in RARE purchases and sales in the last 12 months
- Shehnaaz Suliman - $144K in RARE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John Richard Pinion?
John Richard Pinion is a corporate insider, tracked as EVP, Chief Quality Operations Officer of Ultragenyx Pharmaceutical Inc. (RARE). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did John Richard Pinion last file a Form 4?
The most recent primary Form 4 on record is dated 20 April 2026, one of 2 filings going back to 2026.
Has John Richard Pinion been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($229K) across all tracked filings.
